REKORJA
Live / Applied — Fourth extension granted (statement of use) (as of 19 Aug 2025)
What this means for you
Not registered yet, but its 25 Aug 2021 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90901576
- Mark type
- Stylized text
- Filed
- 25 Aug 2021
- Published for opposition
- 19 Apr 2022
- Attorney of record
- JOEL FELDMAN
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of endocrine diseases and disorders; pharmaceutical preparations for the treatment of psychiatric and neurological diseases and disorders; pharmaceutical preparations for the treatment of Cushing's syndrome and Cushing's disease; pharmaceutical preparations for the treatment of liver disorders, metabolic, cardiovascular, ophthalmic, and gastroenterologic diseases and disorders; in each case, except for cancer
Owner
- CORCEPT THERAPEUTICS INCORPORATED, Redwood City, CA, US
- CORCEPT THERAPEUTICS INCORPORATED, MENLO PARK, CA, US
Prosecution history
- 21 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Aug 2025 — SOU EXTENSION 4 GRANTED
- 19 Aug 2025 — SOU EXTENSION 4 FILED
- 19 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 28 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Feb 2025 — SOU EXTENSION 3 GRANTED
- 27 Feb 2025 — SOU EXTENSION 3 FILED
- 27 Feb 2025 — SOU TEAS EXTENSION RECEIVED
- 26 Sept 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Sept 2024 — SOU EXTENSION 2 GRANTED
- 26 Sept 2024 — SOU EXTENSION 2 FILED
- 26 Sept 2024 — SOU TEAS EXTENSION RECEIVED
- 06 Mar 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Mar 2024 — SOU EXTENSION 1 GRANTED
- 05 Mar 2024 — SOU EXTENSION 1 FILED